Ameriprise’s BlackRock Health Sciences Trust II BMEZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $212K | Buy |
14,521
+1,787
| +14% | +$26K | ﹤0.01% | 3765 |
|
|
2025
Q1 | $190K | Sell |
12,734
-13,155
| -51% | -$196K | ﹤0.01% | 3773 |
|
|
2024
Q4 | $373K | Sell |
25,889
-3,163
| -11% | -$45.5K | ﹤0.01% | 3609 |
|
|
2024
Q3 | $460K | Sell |
29,052
-22,190
| -43% | -$351K | ﹤0.01% | 3498 |
|
|
2024
Q2 | $787K | Sell |
51,242
-10,808
| -17% | -$166K | ﹤0.01% | 3254 |
|
|
2024
Q1 | $1.02M | Sell |
62,050
-13,341
| -18% | -$219K | ﹤0.01% | 3159 |
|
|
2023
Q4 | $1.1M | Sell |
75,391
-6,549
| -8% | -$95.9K | ﹤0.01% | 3142 |
|
|
2023
Q3 | $1.18M | Sell |
81,940
-87,583
| -52% | -$1.26M | ﹤0.01% | 3065 |
|
|
2023
Q2 | $2.78M | Sell |
169,523
-9,248
| -5% | -$152K | ﹤0.01% | 2709 |
|
|
2023
Q1 | $2.99M | Buy |
178,771
+3,763
| +2% | +$62.9K | ﹤0.01% | 2641 |
|
|
2022
Q4 | $2.7M | Buy |
175,008
+487
| +0.3% | +$7.51K | ﹤0.01% | 2671 |
|
|
2022
Q3 | $2.61M | Buy |
174,521
+8,083
| +5% | +$121K | ﹤0.01% | 2658 |
|
|
2022
Q2 | $2.74M | Buy |
166,438
+93,221
| +127% | +$1.53M | ﹤0.01% | 2676 |
|
|
2022
Q1 | $1.46M | Buy |
73,217
+24,332
| +50% | +$484K | ﹤0.01% | 3051 |
|
|
2021
Q4 | $1.24M | Buy |
48,885
+20,521
| +72% | +$521K | ﹤0.01% | 3155 |
|
|
2021
Q3 | $765K | Buy |
28,364
+5,546
| +24% | +$150K | ﹤0.01% | 3268 |
|
|
2021
Q2 | $660K | Sell |
22,818
-96,588
| -81% | -$2.79M | ﹤0.01% | 3359 |
|
|
2021
Q1 | $3.13M | Buy |
119,406
+15,153
| +15% | +$397K | ﹤0.01% | 2666 |
|
|
2020
Q4 | $2.99M | Sell |
104,253
-34,951
| -25% | -$1M | ﹤0.01% | 2592 |
|
|
2020
Q3 | $3.32M | Buy |
139,204
+7,337
| +6% | +$175K | ﹤0.01% | 2359 |
|
|
2020
Q2 | $2.72M | Buy |
+131,867
| New | +$2.72M | ﹤0.01% | 2446 |
|